B. Johnson

发表

2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.

R. Nilakantan, F. Loganzo, A. Wissner, 2005, Journal of medicinal chemistry.

The oxidation of acetophenones to arylglyoxals with aqueous hydrobromic acid in dimethyl sulfoxide

M. B. Floyd, P. Fabio, M. Du, 1985 .

Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)

Ramaswamy Nilakantan, Fei Ye, Allan Wissner, 2003 .

Derivatives of D‐Penicillamine as Potential Antiarthritic Agents.

M. Reich, J. Hanifin, R. Lenhard, 1994 .

Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.

D. Powell, J. Levin, L. Toral-Barza, 2009, Journal of medicinal chemistry.

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Ramaswamy Nilakantan, Allan Wissner, William A. Hallett, 2004, Cancer Research.

Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.

Ramaswamy Nilakantan, Allan Wissner, R. Nilakantan, 2005, Journal of medicinal chemistry.

POTENTIAL ANTIARTHRITIC AGENTS. 2. BENZOYLACETONITRILES AND β-AMINOCINNAMONITRILES

G. Nicolau, A. Sloboda, J. Hanifin, 1980 .

Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.

Rajiv Chopra, Atul Agarwal, Kevin Curran, 2007, Journal of medicinal chemistry.